BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36062762)

  • 101. Noninvasive imaging evaluation of peritoneal recurrence and chemotherapy benefit in gastric cancer after gastrectomy: a multicenter study.
    Sun Z; Wang W; Huang W; Zhang T; Chen C; Yuan Q; Chen Y; Zhou K; Han Z; Feng H; Chen H; Liang X; Hu Y; Yu J; Liu H; Yu L; Xu Y; Li G; Jiang Y
    Int J Surg; 2023 Jul; 109(7):2010-2024. PubMed ID: 37300884
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer.
    Qi TH; Hian OH; Kumaran AM; Tan TJ; Cong TRY; Su-Xin GL; Lim EH; Ng R; Yeo MCR; Tching FLLW; Zewen Z; Hui CYS; Xin WR; Ooi SKG; Leong LCH; Tan SM; Preetha M; Sim Y; Tan VKM; Yeong J; Yong WF; Cai Y; Nei WL; ;
    Breast Cancer Res Treat; 2022 May; 193(1):121-138. PubMed ID: 35262831
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Deep learning radio-clinical signatures for predicting neoadjuvant chemotherapy response and prognosis from pretreatment CT images of locally advanced gastric cancer patients.
    Hu C; Chen W; Li F; Zhang Y; Yu P; Yang L; Huang L; Sun J; Chen S; Shi C; Sun Y; Ye Z; Yuan L; Chen J; Wei Q; Xu J; Xu H; Tong Y; Bao Z; Huang C; Li Y; Du Y; Xu Z; Cheng X
    Int J Surg; 2023 Jul; 109(7):1980-1992. PubMed ID: 37132183
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Integrating tumor and nodal radiomics to predict lymph node metastasis in gastric cancer.
    Yang J; Wu Q; Xu L; Wang Z; Su K; Liu R; Yen EA; Liu S; Qin J; Rong Y; Lu Y; Niu T
    Radiother Oncol; 2020 Sep; 150():89-96. PubMed ID: 32531334
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
    Xu X; Zheng G; Zhang T; Zhao Y; Zheng Z
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):635-646. PubMed ID: 31230156
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Preoperative prediction of Lauren classification in gastric cancer: a radiomics model based on dual-energy CT iodine map.
    Li M; Qin H; Yu X; Sun J; Xu X; You Y; Ma C; Yang L
    Insights Imaging; 2023 Jul; 14(1):125. PubMed ID: 37454355
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Predicting Soft Tissue Sarcoma Response to Neoadjuvant Chemotherapy Using an MRI-Based Delta-Radiomics Approach.
    Fields BKK; Demirjian NL; Cen SY; Varghese BA; Hwang DH; Lei X; Desai B; Duddalwar V; Matcuk GR
    Mol Imaging Biol; 2023 Aug; 25(4):776-787. PubMed ID: 36695966
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Value of spectral CT parameters in predicting the efficacy of neoadjuvant chemotherapy for gastric cancer.
    Deng J; Zhang W; Xu M; Liu X; Ren T; Li S; Sun Q; Xue C; Zhou J
    Clin Radiol; 2024 Jan; 79(1):51-59. PubMed ID: 37914603
    [TBL] [Abstract][Full Text] [Related]  

  • 109. CT-Based Radiomic Score: A Risk Stratifier in Far-Advanced Gastric Cancer Patients.
    Wang L; Zhu L; Yan J; Qin W; Wang C; Xi W; Xu Z; Chen Y; Jiang J; Huang S; Yan C; Zhang H; Pan Z; Zhang J
    Acad Radiol; 2023 Sep; 30 Suppl 1():S220-S229. PubMed ID: 36610930
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Computed tomography imaging phenotypes of hepatoblastoma identified from radiomics signatures are associated with the efficacy of neoadjuvant chemotherapy.
    Chen Y; Froelich MF; Tharmaseelan H; Jiang H; Wang Y; Li H; Tao M; Gao Y; Wang J; Liu J; Schoenberg SO; Feng S; Weis M
    Pediatr Radiol; 2024 Jan; 54(1):58-67. PubMed ID: 37982901
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Clinical Effectiveness of Neoadjuvant Chemotherapy in Gastric Carcinoma and Exploration of Perioperative Imaging Assessment Parameters.
    Lai J; Li J; Mo X
    Gastroenterol Res Pract; 2021; 2021():5563136. PubMed ID: 33981339
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Development of a clinical nomogram for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
    Liu B; Xu YJ; Chu FR; Sun G; Zhao GD; Wang SZ
    World J Gastrointest Surg; 2024 Feb; 16(2):396-408. PubMed ID: 38463346
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Editorial for "Comparison of MRI and CT-Based Radiomics and Their Combination for Early Identification of Pathological Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer".
    Chen PT; Shih TTF
    J Magn Reson Imaging; 2023 Sep; 58(3):924-925. PubMed ID: 36762872
    [No Abstract]   [Full Text] [Related]  

  • 114. Prognostic Value of Inflammatory Burden Index in Advanced Gastric Cancer Patients Undergoing Multimodal Treatment.
    Pelc Z; Sędłak K; Mlak R; Leśniewska M; Mielniczek K; Rola P; Januszewski J; Zhaldak O; Rekowska A; Gęca K; Skórzewska M; Polkowski WP; Pawlik TM; Rawicz-Pruszyński K
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398218
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Multiparametric MRI-based radiomics nomogram for early prediction of pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer.
    Li J; Yin H; Wang Y; Zhang H; Ma F; Li H; Qu J
    Eur Radiol; 2023 Apr; 33(4):2746-2756. PubMed ID: 36512039
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Prediction of response to neoadjuvant chemotherapy in advanced gastric cancer: A radiomics nomogram analysis based on CT images and clinicopathological features.
    Tan X; Yang X; Hu S; Ge Y; Wu Q; Wang J; Sun Z
    J Xray Sci Technol; 2023; 31(1):49-61. PubMed ID: 36314190
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Delta computed tomography radiomics features-based nomogram predicts long-term efficacy after neoadjuvant chemotherapy in advanced gastric cancer.
    Shen LL; Zheng HL; Ding FH; Lu J; Chen QY; Xu BB; Xue Z; Lin J; Huang CM; Zheng CH
    Radiol Med; 2023 Apr; 128(4):402-414. PubMed ID: 36940007
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Risk stratification for 1- to 2-cm gastric gastrointestinal stromal tumors: visual assessment of CT and EUS high-risk features versus CT radiomics analysis.
    Jia X; Wan L; Chen X; Ji W; Huang S; Qi Y; Cui J; Wei S; Cheng J; Chai F; Feng C; Liu Y; Zhang H; Sun Y; Hong N; Rao S; Zhang X; Xiao Y; Ye Y; Tang L; Wang Y
    Eur Radiol; 2023 Apr; 33(4):2768-2778. PubMed ID: 36449061
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Application of radiomics in precision prediction of diagnosis and treatment of gastric cancer.
    Du G; Zeng Y; Chen D; Zhan W; Zhan Y
    Jpn J Radiol; 2023 Mar; 41(3):245-257. PubMed ID: 36260211
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Efficacy and prognostic value of delta radiomics on dual-energy computed tomography for gastric cancer with neoadjuvant chemotherapy: a preliminary study.
    Wang L; Chen Y; Tan J; Ge Y; Xu Z; Wels M; Pan Z
    Acta Radiol; 2023 Apr; 64(4):1311-1321. PubMed ID: 36062762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.